CIM
MRNA icon

CIM Investment Management’s Moderna MRNA Stock Holding History

CIM Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,707
Closed -$203K – 263
2024
Q2 		$203K Buy
+1,707
New +$216K 0.06% 226
2023
Q4 		– Sell
-2,104
Closed -$217K – 290
2023
Q3 		$217K Sell
2,104
-40
-2% -$4.46K 0.08% 234
2023
Q2 		$260K Buy
2,144
+5
+0.2% +$667 0.09% 213
2023
Q1 		$329K Buy
2,139
+86
+4% +$14.2K 0.12% 174
2022
Q4 		$369K Sell
2,053
-48
-2% -$7.85K 0.15% 143
2022
Q3 		$248K Hold
2,101
– – 0.11% 175
2022
Q2 		$300K Sell
2,101
-9
-0.4% -$1.29K 0.12% 162
2022
Q1 		$363K Sell
2,110
-2
-0.1% -$337 0.12% 157
2021
Q4 		$536K Buy
2,112
+925
+78% +$270K 0.16% 135
2021
Q3 		$457K Buy
+1,187
New +$438K 0.14% 146

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIM Investment Management's MRNA Position: Q3 2024 in Review

CIM Investment Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 1,707 shares — an estimated $203K sold.

CIM Investment Management first reported a position in MRNA in Q3 2021 and held it in 10 quarters. The position peaked at $536K in Q4 2021. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • CIM Investment Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • CIM Investment Management sold 1,707 Moderna shares in Q3 2024, an estimated $203K.
  • CIM Investment Management first reported a position in Moderna in Q3 2021 and held it in 10 quarters.
  • CIM Investment Management's Moderna position peaked at $536K in Q4 2021.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on CIM Investment Management's 13F filing for Q3 2024, filed 25 Nov 2024.